Mark For: PLACENTX® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88889244 |
Registration Number | 6503326 |
Mark Literal Elements | PLACENTX |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | TMEG LAW OFFICE 105 2020-07-21 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Ryan D. Artis |
Attorney Docket Number | 206380608833 |
2020-04-27 | Application Filed |
2020-05-14 | Location: NEW APPLICATION PROCESSING |
2020-05-14 | Status: Live/Pending |
2020-05-14 | Transaction Date |
2020-07-21 | Location: TMEG LAW OFFICE 105 |
2020-07-21 | Status: Examiner's Amendment/Priority Action has been sent (issued) to the applicant. The applicant must respond to this Examiner's Amen |
2021-09-28 | Trademark Registered |
Party: | ![]() |
Address | 7630 Plaza Court Willowbrook, ILLINOIS UNITED STATES 60527 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | WYOMING |
![]() | 2020-04-27 | |
![]() | 2020-04-27 | |
![]() | 2020-07-21 | |
![]() | 2020-07-21 | |
![]() | 2020-07-22 | |
![]() | 2020-07-24 | |
![]() | 2020-12-28 | |
![]() | 2021-01-07 | |
![]() | 2021-01-08 | |
![]() | 2021-01-20 | |
![]() | 2021-01-20 | |
![]() | 2021-02-09 | |
![]() | 2021-04-06 | |
![]() | 2021-08-20 | |
![]() | 2021-08-20 | |
![]() | 2021-08-26 | |
![]() | 2021-08-26 | |
![]() | 2021-08-26 | |
![]() | 2021-09-28 |
IC 001. US 001 005 006 010 026 046. G & S: Biological tissue, namely, human tissue for use in scientific and medical research. FIRST USE: 20210101. FIRST USE IN COMMERCE: 20210101
IC 005. US 005 006 018 044 046 051 052. G & S: Biological tissue, namely, liquid placental connective tissue for wound care and treating inflammatory conditions; Human allograft tissue; Biological tissue grafts; Biological human tissue intended for subsequent implantation; Biological implants, namely, a vital processed human or animal connective tissue. FIRST USE: 20210101. FIRST USE IN COMMERCE: 20210101
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Biological tissue, namely, liquid placental connective tissue for wound care and treating inflammatory conditions; Human allograft tissue; Biological tissue grafts; Biological tissue, namely, human tissue for use in scientific and medical research; Biological human tissue intended for subsequent implantation; Biological implants, namely, a vital processed human or animal connective tissue |
GS0011 | Biological tissue, namely, human tissue for use in scientific and medical research |
Description | Date | Proceeding Number |
---|---|---|
REGISTERED-PRINCIPAL REGISTER | 2021-09-28 | |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2021-08-26 | |
STATEMENT OF USE PROCESSING COMPLETE | 2021-08-25 | 70565 |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2021-08-25 | |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-08-24 | 70565 |
USE AMENDMENT FILED | 2021-08-20 | 70565 |
TEAS STATEMENT OF USE RECEIVED | 2021-08-20 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-04-06 | |
PUBLISHED FOR OPPOSITION | 2021-02-09 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-02-09 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-01-20 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-01-07 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-01-06 | 70633 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-01-06 | 70633 |
ASSIGNED TO LIE | 2020-12-29 | 70633 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-12-28 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-07-24 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-07-24 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-07-24 | 88888 |
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2020-07-21 | 6326 |
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | 2020-07-21 | 76079 |
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2020-07-21 | 6326 |
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | 2020-07-21 | 70138 |
ASSIGNED TO LIE | 2020-07-21 | 70138 |
ASSIGNED TO EXAMINER | 2020-07-21 | 76079 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-05-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.